Epilepsy in Sweden: Health care costs and loss of productivity-A register-based approach

European Journal of Health Economics

Volumn 13, Issue 6, 2012, Pages 819-826

  Bolin, Kristian ^a   Lundgren, Anders ^a   Berggren, Fredrik ^b   Kallén, Kristina ^a  

^a LUND UNIVERSITY   (Sweden)

^b Nordic Sugar A/S   (Denmark)

Author keywords

Cost of illness; Epilepsy; Health economics; Pharmaceutical utilisation

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; PRIMIDONE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ABSENTEEISM; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISABILITY; EPILEPSY; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; PRODUCTIVITY; REGISTER; SCHOOL CHILD; SWEDEN;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DRUG COSTS; EPILEPSY; FEMALE; HEALTH CARE COSTS; HUMANS; INFANT; MALE; MIDDLE AGED; REGISTRIES; SEX DISTRIBUTION; SWEDEN; WORK; YOUNG ADULT;

EID: 84870536145     PISSN: 16187598     EISSN: 16187601     Source Type: Journal    
DOI: 10.1007/s10198-011-0361-8     Document Type: Article

References (14)

1. Bolin, K., Lindgren, B.: Smoking, healthcare cost, and loss of productivity in Sweden 2001. Scand. J. Public Health 35, 187-196 (2007)
2. Bolin, K., Gip, C., Mǒrk, A.C., Lindgren, B.: Diabetes, healthcare costs and loss of productivity in Sweden 1987 and 2005-A register-based approach. Diabet. Med. 26, 928-934 (2009)
3. Bolin, K, Borgman, B, Gip, C, Wilson, K.: Current and future avoidable cost of smoking -Estimates for Sweden 2007. Health Policy. 103, 83-91 (2011)
4. Edvinsson, R., Sǒderberg, J.: Consumer price index for Sweden 1290-2006. Paper, Department of Economic History, Stockholm University (2007)
5. Forsgren, I., Beghi, E., Ekman, M.: Cost of epilepsy in Europe. Eur. J. Neuro 12(Suppl. 1), 54-58 (2005)
6. Giuliani, G., Terziani, S., Senigaglia, A.R., et al.: Epilepsy in an Italian community as assessed by a survey for prescriptions of antiepileptic drugs: epidemiology and patterns of care. Acta Neurol. Scand. 85, 23-31 (1992)
7. Ivanova, J.I., Birnbaum, H.G., Kidolezi, Y., et al.: Direct and indirect costs associated with epileptic partial onset seizures among the privately insured in the United States. Epilepsia. 51(5), 838-844 (2010)
8. Lindgren B.: Costs of Illness in Sweden 1964-1975. Lund University Economics Department (1981, diss)
9. Pugliatti, M., Beghi, E., Forsgren, L., Ekman, M., Sobocki, P.: Estimating the cost of epilepsy in Europe: a review with economic modeling. Epilepsia. 48, 2224-2233 (2007)
10. Rice, D.P.: Estimating the Cost of Illness. Health economic series no. 6. Public Health Service. US Government Printing Office, Washington (1966)
11. Silfvenius, H.: Economic costs of epilepsy-treatment benefits. Acta. Neurolgic. Scand. 117, 136-154 (1988)
12. Strzelczyk, A., Reese, J.P., Dodel, R., Hamer, H.M.: Cost of epilepsy-A systematic review. Pharmacoeconomics. 26(6), 463-476 (2008)
13. Tomson, T., Nashef, L., Ryvlin, P.: Sudden unexpected death in epilepsy: current knowledge and future directions. Lancet. Neurol. 8(2), 131-132 (2009)
14. Yoon, D., Kevin, D.F., Deborah, A.C., Joan, K.A.: Economic impact of epilepsy in the United States. Epilepsia. 50(10), 2186-2219 (2009)